Brainsway (BWAY) VP Colleen Hanlon details 53,881 shares and 10,000 options on Form 3

Rhea-AI Filing Summary

Brainsway Ltd. VP of Medical Affairs Colleen Hanlon filed an initial Form 3 detailing her equity position in the company. She directly holds 53,881 Ordinary Shares, including 20,381 shares and multiple RSU grants that vest in quarterly installments through dates extending to March 10, 2030. She also holds stock options over 10,000 Ordinary Shares, granted on March 5, 2024, with an exercise price of NIS 11.17 per share and an expiration date of March 5, 2034, with 5,000 of these options scheduled to vest in equal quarterly installments until March 5, 2028.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Hanlon Colleen

Role VP of Medical Affairs

Type	Security	Shares	Price	Value
holding	Stock Options (right to buy)	--	--	--
holding	Ordinary Shares	--	--	--

Holdings After Transaction: Stock Options (right to buy) — 10,000 shares (Direct); Ordinary Shares — 53,881 shares (Direct)

Footnotes (1)

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. This figure includes: (i) 20,381 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,000 ordinary shares vesting in equal quarterly installments until November 1, 2026, (b) RSUs to receive 2,500 ordinary shares vesting in equal quarterly installments until Mach 5, 2028 and (c) RSUs to receive 25,000 ordinary shares with 6,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. Stock options were granted on March 5, 2024, with the remaining options to purchase 5,000 ordinary shares vesting in equal quarterly installments until March 5, 2028. The exercise price is NIS 11.17 per share

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hanlon Colleen

(Last) (First) (Middle)

16 HARTUM STREET, RAD TOWER, 14TH FLOOR

HAR HAHOTZVIM

(Street)

JERUSALEM 9777516

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Brainsway Ltd. [ BWAY ]

3a. Foreign Trading Symbol
[BWAY]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP of Medical Affairs

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares(1)(2)	53,881	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (right to buy)	(3)	03/05/2034	Ordinary Shares(1)	10,000	(4)	D

Explanation of Responses:

1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

2. This figure includes: (i) 20,381 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,000 ordinary shares vesting in equal quarterly installments until November 1, 2026, (b) RSUs to receive 2,500 ordinary shares vesting in equal quarterly installments until Mach 5, 2028 and (c) RSUs to receive 25,000 ordinary shares with 6,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.

3. Stock options were granted on March 5, 2024, with the remaining options to purchase 5,000 ordinary shares vesting in equal quarterly installments until March 5, 2028.

4. The exercise price is NIS 11.17 per share

	/s/ Colleen Hanlon	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What did Brainsway (BWAY) VP Colleen Hanlon report on her Form 3?

Colleen Hanlon reported her initial ownership of Brainsway Ltd. equity. She holds 53,881 Ordinary Shares, including RSUs vesting over several years, and stock options for 10,000 Ordinary Shares, establishing her starting equity position as an officer.

How many Brainsway (BWAY) shares does Colleen Hanlon beneficially own?

Colleen Hanlon beneficially owns 53,881 Ordinary Shares of Brainsway. This figure includes 20,381 Ordinary Shares plus multiple RSU grants that each convert into one share as they vest on scheduled quarterly dates through March 10, 2030.

What RSU awards are disclosed for Colleen Hanlon in Brainsway (BWAY) stock?

She holds RSUs covering several blocks of Brainsway Ordinary Shares. Awards include 6,000 shares vesting quarterly until November 1, 2026, 2,500 shares vesting quarterly until March 5, 2028, and 25,000 shares vesting through March 10, 2030.

What stock options does Colleen Hanlon hold in Brainsway (BWAY)?

Colleen Hanlon holds options to purchase 10,000 Ordinary Shares of Brainsway. These options were granted on March 5, 2024, have an exercise price of NIS 11.17 per share, and expire on March 5, 2034, with 5,000 options vesting through 2028.

How do Colleen Hanlon’s RSUs in Brainsway (BWAY) vest over time?

Her RSUs vest in structured quarterly schedules. One grant of 6,000 shares vests until November 1, 2026, another 2,500-share grant vests until March 5, 2028, and a 25,000-share grant vests through March 10, 2030, creating long-term equity alignment.

What is the relationship between Brainsway (BWAY) Ordinary Shares and ADSs for Hanlon’s holdings?

Hanlon’s holdings are in Ordinary Shares of Brainsway. A footnote explains that each American Depositary Share (ADS) currently represents one Ordinary Share, so ADSs directly mirror the underlying Ordinary Shares in her reported ownership.